Radboudumc
The expertisecenter Hearing & Genes is a collaboration between the
Otorhinolanyngology and the
Genetics Departments of the Radboud university medical center and one of the acknowledged expertise centers of Amalia children's hospital. Within Hearing & Genes, hearing impaired patients are screened to identify the (hereditary) cause of their hearing loss. The Hearing & Genes Laboratory conducts basic scientific studies to identify novel deafness genes and studies their function in the inner ear. In a multidisciplinary team, we also work on the development of genetic therapy for Usher syndrome (deafblindness) and non-syndromic types of sensorineural hearing loss (f.e. DFNA9). Hearing & Genes values patient-participation and through our close contacts with several patient organisations we aim to improve care for our patients and strive for a more permanent solution of hereditary hearing loss. Hearing & Genes has initiated a collaboration with the Radboudumc Technology Center for Clinical Studies to foster H&G-trials for inner ear molecular therapies in the upcoming years.
Novel medical therapies for (hereditary) hearing loss are currently being developed and will be introduced as clinical trials in the upcoming years. These novel treatments need careful evaluation and implementation and Hearing & Genes wants to play an international leading role in this development. Next to clinical trials, we also wants to conduct natural history studies to evaluate progression of hearing (and in Usher syndrome vision) loss as they will form the basis for future genetic therapy trials.
RadboudumcRadboudumc strives to be a leading developer of sustainable, innovative and affordable healthcare to improve the health and wellbeing of people and society in the Netherlands and beyond. This is the core of our mission: To have a significant impact on healthcare. To get a better picture of what this entails, check out our
strategy film.
Read more about what it means
to work at Radboudumc and how you can do your part.